Delivery Order SPE2DB22D1017-SPE2DB25FF8PN
Award Date 3/26/25
Potential Completion Date 4/16/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract has a firm fixed price of $1,302.54 and a period of performance through April 28, 2025. There is no set-aside designation for this award. In addition to this delivery order, AmerisourceBergen...
- This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,215.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical...
- This is a $3,037.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA) in 0.25 mL doses. The contract is not designated as a set-aside and represents a single delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a $1,290 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 27, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,692.20 firm fixed-price contract is for the supply of Moderna COVID-19 vaccine doses for children aged 6 months to 11 years under the Emergency Use Authorization (EUA). This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 2025, which...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,290.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group, under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,290.00 and an ultimate completion date of February 11, 2025. This award is part of a larger...
- This federal contract award is for the delivery of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a major U.S. Department of Defense (DoD) agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen, a large...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FF8PNDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccine doses for 6-month to 11-year-old recipients under the Emergency Use Authorization (EUA). The fixed-price delivery order, valued at $1,302.54, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 6/29/25, 12:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/26/25 |